Breakthrough obesity treatments on the horizon, rivaling surgery’s success

New obesity pharmacotherapies, including GLP-1 receptor agonists and combinations of entero-pancreatic hormones, show promise in achieving significant weight loss, potentially rivaling bariatric surgery’s effectiveness.

Pharma is betting big on connecting potential patients to its medications. It’s just the beginning

Pharma companies are getting more serious about telehealth. In the past three months, Eli Lilly launched a splashy website connecting consumers with places to get

April 3, 2024

UAB researchers reverse liver disease in mice with gene therapy

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that

November 14, 2024

MarketingRx roundup: Eli Lilly’s marketing chief at Cannes Lions, Biogen raises more Alzheimer’s awareness

Eli Lilly’s chief corporate brand officer, Lina Polemini, joined two other marketing leaders at Cannes Lions on Monday to talk about what it means to

June 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.